Clinical Trial Update: 18F-Fluciclovine PET/CT in the Assessment of Pancreatic Transplants [EARLY_Phase 1]

View source ↗

Summary

Phase 1 study update evaluating 18F-Fluciclovine PET/CT for assessing pancreatic transplant status, including graft dysfunction and rejection, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Transplant Rejection
• Pancreatitis

Drugs mentioned

• 18F-Fluciclovine (fluorine-18-fluciclovine)

Snippet

Sponsor: University of Utah | Conditions: Pancreatitis, Graft, Pancreatic Transplant Post-Transplant Dysfunction Rejection | EARLY_Phase 1 | Status: COMPLETED